Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UTI-Free is a multi-ingredient dietary supplement developed by MEDITRINA for the protection and support of the urinary tract. It contains a combination of D-mannose, L-methionine, L-ascorbic acid (Vitamin C), and calcium carbonate. D-mannose acts by inhibiting the adhesion of bacteria, such as *Escherichia coli*, to the urothelium, facilitating their natural removal through urine. L-methionine serves as a metabolic precursor that leads to the acidification of urine, creating an environment that inhibits bacterial growth and further prevents adhesion. Vitamin C provides antioxidant protection and supports the normal functioning of the immune system. The product is available in sachet form for oral administration and is intended for the prevention of recurrent urinary tract infections and the maintenance of normal urinary flora.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on UTI-Free.